Veterinary Medicines

OTOMAX EAR DROPS SUSPENSION

Authorised
  • Gentamicin sulfate
  • Clotrimazole
  • Betamethasone valerate
Download as PDF

Product identification

Medicine name:
OTOMAX EAR DROPS SUSPENSION
Otomax Ohrentropfen
Active substance:
  • Gentamicin sulfate
  • Clotrimazole
  • Betamethasone valerate
Target species:
  • Dog
Route of administration:
  • Auricular use

Product details

Active substance and strength:
  • Gentamicin sulfate
    2640.00
    international unit(s)
    /
    1.00
    millilitre(s)
  • Clotrimazole
    8.80
    milligram(s)
    /
    1.00
    millilitre(s)
  • Betamethasone valerate
    1.07
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Ear drops, suspension
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QS02CA90
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Germany
Available in:
  • Germany
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Intervet Deutschland GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Trirx Segre
Responsible authority:
  • Federal Office Of Consumer Protection And Food Safety
Authorisation number:
  • 400382.00.00
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0110/001
Concerned member states:
  • Austria
  • Belgium
  • Denmark
  • Finland
  • Germany
  • Greece
  • Ireland
  • Italy
  • Luxembourg
  • Portugal
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 12/08/2025
Download